Skip to main content

Table 2 Characteristics of study population

From: Targeted CYP2E1 quantification and its correlation to currently acceptable clinical biochemical indices

Variables

Study groupings

C (n = 45)

Pre-D (n = 25)

D (n = 96)

Gender

 M

12

12

47

 F

33

13

49

Age (years)

42 ± 13

50 ± 11

54 ± 9

HbA1c (%)

4.4 ± 0.36

6.0 ± 0.39

8.7 ± 2.0

FBS (mmol L−1)

4.9 ± 0.48

6.0 ± 1.16

10.0 ± 4.68

CYP2E1 (ag µL−1)

 

0 ± 0

7.66 ± 16.39

10.0 ± 20.79

 p

C vs Pre-D: p < 0.001 C vs D: p < 0.001

Pre-D vs D: p = 0.905

  1. Data are presented as mean ± SD
  2. C control, Pre-D pre-diabetes, D diabetes, m male, f female, FBS fasting blood sugar